162 related articles for article (PubMed ID: 8819180)
21. Selected methods for the evaluation of the effects of drugs on mucus viscoelasticity and mucociliary clearance.
Bell AE; James SL; Marriott C
Biorheology Suppl; 1984; 1():127-30. PubMed ID: 6332650
[TBL] [Abstract][Full Text] [Related]
22. Mucoactive medications and airway disease.
Majima Y
Paediatr Respir Rev; 2002 Jun; 3(2):104-9. PubMed ID: 12297055
[TBL] [Abstract][Full Text] [Related]
23. Tracheobronchial function in health and disease. Effect of mucolytic substances.
Melville GN; Ismail S; Sealy C
Respiration; 1980; 40(6):329-36. PubMed ID: 7221201
[TBL] [Abstract][Full Text] [Related]
24. The role of mucus in cough research.
Rubin BK
Lung; 2010 Jan; 188 Suppl 1():S69-72. PubMed ID: 19936981
[TBL] [Abstract][Full Text] [Related]
25. The effect of tasuldine, a bronchosecretolytic agent, on mucus rheology and clearability and the interaction with acetylcholine in ferrets.
App EM; Tomkiewicz RP; Hahn HL; Engler H; Vergin H; King M
Pulm Pharmacol Ther; 1997; 10(5-6):271-6. PubMed ID: 9778490
[TBL] [Abstract][Full Text] [Related]
26. Model systems for the evaluation of mucolytic drugs: acetylcysteine and S-carboxymethylcysteine.
Livingstone CR; Andrews MA; Jenkins SM; Marriott C
J Pharm Pharmacol; 1990 Feb; 42(2):73-8. PubMed ID: 1972405
[TBL] [Abstract][Full Text] [Related]
27. Aerosol Medications for Treatment of Mucus Clearance Disorders.
Rubin BK
Respir Care; 2015 Jun; 60(6):825-9; discussion 830-32. PubMed ID: 26070577
[TBL] [Abstract][Full Text] [Related]
28. 50 years ago in the Journal of Pediatrics: the effect of N-acetylcysteine on the viscosity of tracheobronchial secretions in cystic fibrosis of the pancreas.
Bear CE
J Pediatr; 2013 Jan; 162(1):85. PubMed ID: 23260312
[No Abstract] [Full Text] [Related]
29. Effect of N-acetylcysteine on mucosal immunity of respiratory tract.
Kalyuzhin OV
Ter Arkh; 2018 Apr; 90(3):89-95. PubMed ID: 30701862
[TBL] [Abstract][Full Text] [Related]
30. Ferret tracheal mucus rheology, clearability and volume following administration of substance P or methacholine.
De Sanctis GT; Rubin BK; Ramirez O; King M
Eur Respir J; 1993 Jan; 6(1):76-82. PubMed ID: 7678818
[TBL] [Abstract][Full Text] [Related]
31. Effect of the mucoactive drug nacystelyn on the respiratory burst of human blood polymorphonuclear neutrophils.
Nagy AM; Vanderbist F; Parij N; Maes P; Fondu P; Nève J
Pulm Pharmacol Ther; 1997; 10(5-6):287-92. PubMed ID: 9778492
[TBL] [Abstract][Full Text] [Related]
32. Deposition of nacystelyn from a dry powder inhaler in healthy volunteers and cystic fibrosis patients.
Vanderbist F; Wery B; Baran D; Van Gansbeke B; Schoutens A; Moës AJ
Drug Dev Ind Pharm; 2001; 27(3):205-12. PubMed ID: 11291200
[TBL] [Abstract][Full Text] [Related]
33. Interaction between ion transporters and the mucociliary transport system in dog and baboon.
Winters SL; Yeates DB
J Appl Physiol (1985); 1997 Oct; 83(4):1348-59. PubMed ID: 9338446
[TBL] [Abstract][Full Text] [Related]
34. Effect of guaifenesin on mucin production, rheology, and mucociliary transport in differentiated human airway epithelial cells.
Seagrave J; Albrecht H; Park YS; Rubin B; Solomon G; Kim KC
Exp Lung Res; 2011 Dec; 37(10):606-14. PubMed ID: 22044398
[TBL] [Abstract][Full Text] [Related]
35. Nacystelyn enhances adenoviral vector-mediated gene delivery to mouse airways.
Kushwah R; Oliver JR; Cao H; Hu J
Gene Ther; 2007 Aug; 14(16):1243-8. PubMed ID: 17525704
[TBL] [Abstract][Full Text] [Related]
36. Species differences in the physical and transport properties of airway secretions.
Tomkiewicz RP; Albers GM; De Sanctis GT; Ramirez OE; King M; Rubin BK
Can J Physiol Pharmacol; 1995 Feb; 73(2):165-71. PubMed ID: 7621353
[TBL] [Abstract][Full Text] [Related]
37. Influence of tasuldine and acetylcysteine on mucociliary clearance in patients with chronic airways obstruction.
Dorow P; Weiss T; Felix R; Köhler M
Arzneimittelforschung; 1986; 36(1):131-3. PubMed ID: 3954815
[TBL] [Abstract][Full Text] [Related]
38. Effect of air humidity on spinability and transport capacity of canine airway secretions.
Puchelle E; Zahm JM; Jacquot J; Pierrot D
Biorheology; 1989; 26(2):315-22. PubMed ID: 2605335
[TBL] [Abstract][Full Text] [Related]
39. The pharmacologic approach to airway clearance: mucoactive agents.
Rubin BK
Paediatr Respir Rev; 2006; 7 Suppl 1():S215-9. PubMed ID: 16798570
[TBL] [Abstract][Full Text] [Related]
40. Experimental models for studying mucociliary clearance.
King M
Eur Respir J; 1998 Jan; 11(1):222-8. PubMed ID: 9543296
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
